New diabetes clinical trial: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Published on: October 09, 2025 at 11:00PM
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: LY3938577; Drug: Degludec
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/wQNlb9W
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: LY3938577; Drug: Degludec
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/wQNlb9W
Comments
Post a Comment